Canaccord Reiterates Buy Rating on Concentrix With $80 Price Target

Summary

Canaccord Genuity Group reaffirmed its ‘buy’ rating for Concentrix (NASDAQ: CNXC) with a target price of $80.00, suggesting a potential upside of 51.08%. The stock price increased by 2.4% to $52.95, and the company’s market cap is $3.38 billion. The reported earnings per share were $2.70, which missed expectations, though revenue increased by 1.5% year-over-year. Significant insider selling occurred, and institutional investors have recently increased their holdings.Market Beat

Impact Analysis

The reaffirmation of the ‘buy’ rating by Canaccord at the company level suggests confidence in Concentrix’s potential to reach a higher valuation, despite a recent earnings miss. This is significant as the stock price has risen 2.4% to $52.95, while the target price indicates a 51.08% upside.Market Beat Other analysts have varying views, with price targets ranging from $54 to $72, reflecting differing levels of optimism or caution, which portrays a mixed sentiment in the market.Market Beat+ 3 The increase in institutional holdings suggests confidence in long-term prospects despite insider selling, which may raise concerns about management’s view of the stock’s current valuation. Investors could see this as an opportunity for significant gains if the price approaches the target, but should weigh the risks associated with the earnings miss and insider selling.